Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MDMA ECSTASY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McElrath, K; McEvoy, K
      Fact, fiction, and function: Mythmaking and the social construction of ecstasy use

      SUBSTANCE USE & MISUSE
    2. Doyon, S
      The many faces of ecstasy

      CURRENT OPINION IN PEDIATRICS
    3. Halladay, AK; Kirschner, E; Hesse, K; Fisher, H; Wagner, GC
      Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release

      PHARMACOLOGY & TOXICOLOGY
    4. Murai, T; Muller, U; Werheid, K; Sorger, D; Reuter, M; Becker, T; von Cramon, DY; Barthel, H
      In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    5. Bai, FJ; Jones, DC; Lau, SS; Monks, TJ
      Serotonergic neurotoxicity of 3,4-(+/-) -methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

      CHEMICAL RESEARCH IN TOXICOLOGY
    6. Taffe, MA; Weed, MR; Davis, S; Huitron-Resendiz, S; Schroeder, R; Parsons, LH; Henriksen, SJ; Gold, LH
      Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine(MDMA) treatment in rhesus monkeys

      NEUROPSYCHOPHARMACOLOGY
    7. McCann, UD; Ricaurte, GA
      Caveat emptor: Editors beware

      NEUROPSYCHOPHARMACOLOGY
    8. Shankaran, M; Yamamoto, BK; Gudelsky, GA
      Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT

      SYNAPSE
    9. Reneman, L; De Bruin, K; Lavalaye, J; Gunning, WB; Booij, J
      Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [I-123]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus

      SYNAPSE
    10. Winstock, AR; Griffiths, P; Stewart, D
      Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK

      DRUG AND ALCOHOL DEPENDENCE
    11. Carvalho, M; Carvalho, F; Bastos, ML
      Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

      ARCHIVES OF TOXICOLOGY
    12. Vaiva, G; Boss, V; Bailly, D; Thomas, P; Lestavel, P; Goudemand, M
      An "accidental"' acute psychosis with ecstasy use

      JOURNAL OF PSYCHOACTIVE DRUGS
    13. O'Loinsigh, ED; Boland, G; Kelly, JP; O'Boyle, KM
      Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    14. Teter, CJ; Guthrie, SK
      A comprehensive review of MDMA and GHB: Two common club drugs

      PHARMACOTHERAPY
    15. Pham, JV; Puzantian, T
      Ecstasy: Dangers and controversies

      PHARMACOTHERAPY
    16. Gamma, A; Buck, A; Berthold, T; Vollenweider, FX
      No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine)users and control subjects: A [(H2O)-O-15]-positron emission tomography study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    17. Broening, HW; Morford, LL; Inman-Wood, SL; Fukumura, M; Vorhees, CV
      3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development

      JOURNAL OF NEUROSCIENCE
    18. Pedersen, NP; Blessing, WW
      Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy) in conscious rabbits

      JOURNAL OF NEUROSCIENCE
    19. Garbino, J; Henry, JA; Mentha, G; Romand, JA
      Ecstasy ingestion and fulminant hepatic failure: Liver transplantation to be considered as a last therapeutic option

      VETERINARY AND HUMAN TOXICOLOGY
    20. Buchert, R; Obrocki, J; Thomasius, R; Vaterlein, O; Petersen, K; Jenicke, L; Bohuslavizki, KH; Clausen, M
      Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET

      NUCLEAR MEDICINE COMMUNICATIONS
    21. Russell, BR; Laverty, R
      The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    22. Grinspoon, L; Doblin, R
      Psychedelics as catalysts of insight-oriented psychotherapy

      SOCIAL RESEARCH
    23. Murray, JB
      Ecstasy is a dangerous drug

      PSYCHOLOGICAL REPORTS
    24. Spitzer, M; Franke, B; Walter, H; Buechler, J; Wunderlich, AP; Schwab, M; Kovar, KA; Hermle, L; Gron, G
      Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans

      NEUROPHARMACOLOGY
    25. Harkin, A; Connor, TJ; Mulrooney, J; Kelly, JP; Leonard, BE
      Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

      LIFE SCIENCES
    26. Acquas, E; Marrocu, P; Pisanu, A; Cadoni, C; Zernig, G; Saria, A; Di Chiara, G
      Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Reneman, L; Majoie, CBLM; Schmand, B; van den Brink, W; den Heeten, GJ
      Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: Preliminary report

      BIOLOGICAL PSYCHIATRY
    28. Esteban, B; O'Shea, E; Camarero, J; Sanchez, V; Green, AR; Colado, MI
      3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected nenrotoxic dose

      PSYCHOPHARMACOLOGY
    29. Liechti, ME; Gamma, A; Vollenweider, FX
      Gender differences in the subjective effects of MDMA

      PSYCHOPHARMACOLOGY
    30. Balmelli, C; Kupferschmidt, H; Rentsch, K; Schneemann, M
      Fatal brain oedema after ingestion of ecstasy and benzylpiperazine

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    31. Van Aerts, LAGJM; Mallaret, M; Rigter, H
      N-methyl-1-(1,3-benzodioxol-5-yl)-2-buta (MBDB): its properties and possible risks

      ADDICTION BIOLOGY
    32. Gamma, A; Frei, E; Lehmann, D; Pascual-Marqui, RD; Hell, D; Vollenweider, FX
      Mood state and brain electric activity in Ecstasy users

      NEUROREPORT
    33. Carter, N; Rutty, GN; Milroy, CM; Forrest, ARW
      Deaths associated with MBDB misuse

      INTERNATIONAL JOURNAL OF LEGAL MEDICINE
    34. Iravani, MM; Asari, D; Patel, J; Wieczorek, WJ; Kruk, ZL
      Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin ordopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulate, and the dorsal raphe nucleus slices

      SYNAPSE
    35. Morland, J
      Toxicity of drug abuse - amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use

      TOXICOLOGY LETTERS
    36. McCann, UD; Eligulashvili, V; Ricaurte, GA
      (+/-)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Clinical studies

      NEUROPSYCHOBIOLOGY
    37. Parrott, AC
      Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: Cognitive and behavioural indices of change

      NEUROPSYCHOBIOLOGY
    38. Turner, JJD; Parrott, AC
      'Is MDMA a human neurotoxin?': Diverse views from the discussants

      NEUROPSYCHOBIOLOGY
    39. Cami, J; Farre, M; Mas, M; Roset, PN; Poudevida, S; Mas, A; San, L; de la Torre, R
      Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): Psychomotor performance and subjective effects

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    40. Liechti, ME; Vollenweider, FX
      The serotonin uptake inhibitor citalopram reduces acute cardiovascular andvegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    41. Garcia-Osta, A; Frechilla, D; Del Rio, J
      Effect of p-chloroamphetamine on 5-HT1A and 5-HT7 serotonin receptor expression in rat brain

      JOURNAL OF NEUROCHEMISTRY
    42. Behan, WMH; Madigan, M; Clark, BJ; Goldberg, J; McLellan, DR
      Muscle changes in the neuroleptic malignant syndrome

      JOURNAL OF CLINICAL PATHOLOGY
    43. Shirayama, Y; Hashimoto, K; Iyo, M; Watanabe, K; Higuchi, T; Minabe, Y
      3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    44. Burrows, KB; Gudelsky, G; Yamamoto, BK
      Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. Clauwaert, KM; Van Bocxlaer, JF; De Letter, EA; Van Calenbergh, S; Lambert, WE; De Leenheer, AP
      Determination of the designer drugs 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine

      CLINICAL CHEMISTRY
    46. Henry, JA
      Metabolic consequences of drug misuse

      BRITISH JOURNAL OF ANAESTHESIA
    47. Gerra, G; Zaimovic, A; Ferri, M; Zambelli, U; Timpano, M; Neri, E; Marzocchi, GF; Delsignore, R; Brambilla, F
      Long-lasting effects of (+/-)3,4-methylene-dioxymethamphetamine (ecstasy) on serotonin system function in humans

      BIOLOGICAL PSYCHIATRY
    48. Reneman, L; Booij, J; Schmand, B; van den Brink, W; Gunning, B
      Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

      PSYCHOPHARMACOLOGY
    49. Tagliaro, F; De Battisti, Z; Groppi, A; Nakahara, Y; Scarcella, D; Valentini, R; Marigo, M
      High sensitivity simultaneous determination in hair of the major constituents of ecstasy (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxyethylamphetamine) by high-performance liquid chromatography with direct fluorescence detection

      JOURNAL OF CHROMATOGRAPHY B
    50. Aguirre, N; Barrionuevo, M; Ramirez, MJ; Del Rio, J; Lasheras, B
      alpha-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

      NEUROREPORT
    51. Stumm, G; Schlegel, J; Schafer, T; Wurz, C; Mennel, HD; Krieg, JC; Vedder, H
      Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons

      FASEB JOURNAL
    52. Hall, FS; DeVries, AC; Fong, GW; Huang, S; Pert, A
      Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels onextracellular serotonin in the striatum assessed with in vivo microdialysis: Relationship to behavior

      SYNAPSE
    53. McAvoy, Y; Cole, MD; Gueniat, O
      Analysis of amphetamines by supercritical fluid chromatography, high-performance liquid chromatography, gas chromatography and capillary zone electrophoresis; a preliminary comparison

      FORENSIC SCIENCE INTERNATIONAL
    54. Topp, L; Hando, J; Dillon, P; Roche, A; Solowij, N
      Ecstasy use in Australia: patterns of use and associated harm

      DRUG AND ALCOHOL DEPENDENCE
    55. Stephenson, CP; Hunt, GE; Topple, AN; McGregor, IS
      The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain

      NEUROSCIENCE
    56. Jayanthi, S; Ladenheim, B; Andrews, AM; Cadet, JL
      Overexpression of human copper zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy)

      NEUROSCIENCE
    57. Hatzidimitriou, G; McCann, UD; Ricaurte, GA
      Altered serotonin innervation patterns in the forebrain of monkeys treatedwith (+/--)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery

      JOURNAL OF NEUROSCIENCE
    58. Milroy, CM
      Ten years of 'ecstasy'

      JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
    59. Holmes, SB; Banerjee, AK; Alexander, WD
      Hyponatraemia and seizures after ecstasy use

      POSTGRADUATE MEDICAL JOURNAL
    60. Theune, M; Esser, W; Druschky, KF; Interschick, E; Patscheke, H
      Series of grand mal seizures after consumption of Ecstasy

      NERVENARZT
    61. Mas, M; Farre, M; De la Torre, R; Roset, PN; Ortuno, J; Segura, J; Cami, J
      Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    62. Shankaran, M; Yamamoto, BK; Gudelsky, GA
      Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum

      JOURNAL OF NEUROCHEMISTRY
    63. Kuhn, DM; Geddes, TJ
      Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation - Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    64. Shankaran, H; Yamamoto, BK; Gudelsky, GA
      Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    65. Obrocki, J; Buchert, R; Vaterlein, O; Thomasius, R; Beyer, W; Schiemann, T
      Ecstasy - long-term effects on the human central nervous system revealed by positron emission tomography

      BRITISH JOURNAL OF PSYCHIATRY
    66. Marston, HM; Reid, ME; Lawrence, JA; Olverman, HJ; Butcher, SP
      Behavioural analysis of the acute and chronic effects of MDMA treatment inthe rat

      PSYCHOPHARMACOLOGY
    67. Gouzoulis-Mayfrank, E; Thelen, B; Habermeyer, E; Kunert, HJ; Kovar, KA; Lindenblatt, H; Hermle, L; Spitzer, M; Sass, H
      Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study

      PSYCHOPHARMACOLOGY
    68. SCHUSTER P; LIEB R; LAMERTZ C; WITTCHEN HU
      IS THE USE OF ECSTASY AND HALLUCINOGENS INCREASING - RESULTS FROM A COMMUNITY STUDY

      European addiction research
    69. BENGEL D; ISAACS KR; HEILS A; LESCH KP; MURPHY DL
      THE APPETITE-SUPPRESSANT D-FENFLURAMINE INDUCES APOPTOSIS IN HUMAN SEROTONERGIC CELLS

      NeuroReport
    70. VOLLENWEIDER FX; GAMMA AG; LIECHTI M; HUBER T
      PSYCHOLOGICAL AND CARDIOVASCULAR EFFECTS AND SHORT-TERM SEQUELAE OF MDMA (ECSTASY) IN MDMA-NAIVE HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    71. KELLER T; MIKI A; REGENSCHEIT P; DIRNHOFER R; SCHNEIDER A; TSUCHIHASHI H
      DETECTION OF DESIGNER DRUGS IN HUMAN HAIR BY ION MOBILITY SPECTROMETRY (IMS)

      Forensic science international
    72. Ropero-Miller, JD; Goldberger, BA
      Recreational drugs - Current trends in the 90s

      CLINICS IN LABORATORY MEDICINE
    73. WINDHABER J; MAIERHOFER D; DANTENDORFER K
      PANIC DISORDER-INDUCED BY LARGE DOSES OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE RESOLVED BY PAROXETINE

      Journal of clinical psychopharmacology
    74. GERRA G; ZAIMOVIC A; FRANCHINI D; PALLADINO M; GIUCASTRO G; REALI N; MAESTRI D; CACCAVARI R; DELSIGNORE R; BRAMBILLA F
      NEUROENDOCRINE RESPONSES OF HEALTHY-VOLUNTEERS TO TECHNO-MUSIC - RELATIONSHIPS WITH PERSONALITY-TRAITS AND EMOTIONAL STATE

      International journal of psychophysiology
    75. Ferigolo, M; Medeiros, FB; Barros, HMT
      "Ecstasy": a pharmacological review

      REVISTA DE SAUDE PUBLICA
    76. MAS M; FARRE M; ROSET PN; CAMI J
      TOXICITY OF ECSTASY

      Medicina Clinica
    77. LAPOSTOLLE F; ELIEZ CA; ELMASSIOUI Y; ADNET F; LECLERC G; EFTHYMIOU ML; BAUD F
      TOXIC EFFECT OF ECSTASY

      La Presse medicale
    78. THOMASIUS R; SCHMOLKE M; KRAUS D
      MDMA(ECSTASY)-CONSUMPTION - A SURVEY OF P SYCHIATRIC AND MEDICAL CONSEQUENCES

      Fortschritte der Neurologie, Psychiatrie
    79. ROTHE M; PRAGST F; SPIEGEL K; HARRACH T; FISCHER K; KUNKEL J
      HAIR CONCENTRATIONS AND SELF-REPORTED ABUSE HISTORY OF 20 AMPHETAMINEAND ECSTASY USERS

      Forensic science international
    80. LANE R; BALDWIN D
      SELECTIVE SEROTONIN REUPTAKE INHIBITOR-INDUCED SEROTONIN SYNDROME - REVIEW

      Journal of clinical psychopharmacology
    81. ARENAS MAR; ANTA GB; DEHOZ LD; ROYUELA L; DOMINGUEZ M; MATIA J; VICENTE J; SEBASTIAN E
      EMERGENCIES ASSOCIATED WITH THE CONSUMPTI ON OF DESIGN DRUGS, HALLUCINOGENS AND AMPHETAMINES ATTENDED AT 15 SPANISH HOSPITALS DURING 1994

      Revista Clinica Espanola
    82. HALL AP
      ECSTASY AND THE ANESTHETIST

      British Journal of Anaesthesia
    83. BURNAT P; LEBRUMANTPAYEN C; HUART B; CEPPA F; PAILLER FM
      ECSTASY - PSYCHOSTIMULANT, HALLUCINOGEN A ND TOXIC

      La Presse medicale
    84. IWERSEN S; SCHMOLDT A
      2 VERY DIFFERENT FATAL CASES ASSOCIATED WITH THE USE OF METHYLENEDIOXYETHYLAMPHETAMINE (MDEA) - EVE AS DEADLY AS ADAM

      Journal of toxicology. Clinical toxicology
    85. HALL AP; LYBURN ID; SPEARS FD; RILEY B
      AN UNUSUAL CASE OF ECSTASY POISONING

      Intensive care medicine
    86. CAMI J; FARRE M
      EXTASIS, THE DRUG ON THE [[ROUTE OF THE B AKALAO]] IN SPAIN

      Medicina Clinica
    87. GARTSIDE SE; MCQUADE R; SHARP T
      EFFECTS OF REPEATED ADMINISTRATION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ON 5-HYDROXYTRYPTAMINE NEURONAL-ACTIVITY AND RELEASE IN THE RAT-BRAIN IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    88. MILROY CM; CLARK JC; FORREST ARW
      PATHOLOGY OF DEATHS ASSOCIATED WITH ECSTASY AND EVE MISUSE

      Journal of Clinical Pathology
    89. HEGADOREN KM; BAKER GB; COUTTS RT
      ANALYSIS OF THE ENANTIOMERS OF 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE, EVE) AND ITS METABOLITE 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) IN RAT-BRAIN

      Journal of pharmacological and toxicological methods
    90. MCNAMARA MG; KELLY JP; LEONARD BE
      THE EFFECT OF ACUTE MDMA ADMINISTRATION ON BODY-TEMPERATURE, SERUM CORTICOSTERONE AND NEUROTRANSMITTER CONCENTRATIONS IN MALE AND FEMALE RATS

      Human psychopharmacology
    91. KRAMER HK; POBLETE JCP; AZMITIA EC
      3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) PROMOTES THE TRANSLOCATION OF PROTEIN-KINASE-C (PKC) - REQUIREMENT OF VIABLE SEROTONIN NERVE-TERMINALS

      Brain research
    92. HOOFT PJ; VANDEVOORDE HP
      RECKLESS BEHAVIOR RELATED TO THE USE OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) - APROPOS OF A FATAL ACCIDENT DURING CAR-SURFING

      International journal of legal medicine
    93. BRONSON ME; JIANG WW; CLARK CR; DERUITER J
      EFFECTS OF DESIGNER DRUGS ON THE CHICKEN-EMBRYO AND 1-DAY-OLD CHICKEN

      Brain research bulletin
    94. ORANJE WA; VONPOL P; VONDERWURFF A; ZEIJEN RNM; STOCKBRUGGER RW; ARENDS JW
      XTC-INDUCED HEPATITIS

      Netherlands journal of medicine
    95. GOUZOULISMAYFRANK E; HERMLE L
      THE DANGERS OF THE DRUG ECTASIA

      Nervenarzt
    96. MCGUIRE PK; COPE H; FAHY TA
      DIVERSITY OF PSYCHOPATHOLOGY ASSOCIATED WITH USE OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)

      British Journal of Psychiatry
    97. OCONNOR B
      HAZARDS ASSOCIATED WITH THE RECREATIONAL DRUG ECSTASY

      British Journal of Hospital Medicine
    98. TUCKER GT; LENNARD MS; ELLIS SW; WOODS HF; CHO AK; LIN LY; HIRATSUKA A; SCHMITZ DA; CHU TYY
      THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6)

      Biochemical pharmacology
    99. MCCANN UD; RICAURTE GA
      REINFORCING SUBJECTIVE EFFECTS OF (+ -) 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) MAY BE SEPARABLE FROM ITS NEUROTOXIC ACTIONS - CLINICAL-EVIDENCE/

      Journal of clinical psychopharmacology
    100. WODARZ N; BONING J
      ECSTASY - INDUCED PSYCHOTIC DEPERSONALIZA TION DISORDER

      Nervenarzt


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 05:49:56